Glox Therapeutics

Glox Therapeutics develops precision antibiotic therapies based on naturally occurring bacteriocins. Their platform enables the creation of potent therapeutics that selectively target drug-resistant bacteria without harming the human microbiome, addressing the urgent need for effective treatments against antimicrobial-resistant lung infections, particularly in cystic fibrosis patients.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: £500K

Date: 21-Jan-2025

Investors: LifeArc

Markets: Biotechnology, Pharmaceuticals, Antimicrobials, Drug Discovery, HealthTech, Life Sciences

HQ: Glasgow, Scotland, United Kingdom

Founded: 2023

Website: https://gloxtherapeutics.com/

LinkedIn: https://www.linkedin.com/company/glox-therapeutics-ltd/

Twitter: https://twitter.com/GloxThera

Instagram: